MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 110 filers reported holding MYOVANT SCIENCES LTD in Q2 2021. The put-call ratio across all filers is 4.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,078,000 | +33.4% | 60,000 | -7.7% | 1.49% | +31.7% |
| Q2 2022 | $808,000 | -28.6% | 65,000 | -23.5% | 1.13% | -5.7% |
| Q1 2022 | $1,132,000 | -14.4% | 85,000 | 0.0% | 1.20% | +25.3% |
| Q4 2021 | $1,323,000 | -30.6% | 85,000 | 0.0% | 0.96% | -3.2% |
| Q3 2021 | $1,907,000 | -4.3% | 85,000 | -2.9% | 0.99% | -3.5% |
| Q2 2021 | $1,993,000 | – | 87,500 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |